|Bid||44.45 x 800|
|Ask||44.46 x 800|
|Day's Range||44.13 - 45.00|
|52 Week Range||32.99 - 46.29|
|Beta (5Y Monthly)||0.88|
|PE Ratio (TTM)||315.67|
|Earnings Date||Oct 26, 2021 - Nov 01, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||50.87|
Investors are optimistic about Boston Scientific (BSX) given its recent acquisitions and strength in the structural heart business.
In this article, we will be taking a look at the 10 healthcare stocks to buy according to billionaire Noam Gottesman’s GLG Partners. If you want to skip our detailed analysis about the fund and its owner, go directly to the 5 Healthcare Stocks to Buy According to Billionaire Noam Gottesman’s GLG Partners. Noam Gottesman […]
The Baylis Medical buyout is expected to expand Boston Scientific's (BSX) electrophysiology and structural heart product offerings.